This inventor holds 2 USPTO granted patents. Top assignees: Purdue Research Foundation, Centers for Disease Control and Prevention. Active years: 2006-2011.
Company Filing History:
2 out of 2,773 
1 out of 26 
Years Active: 2006-2011
Title: David A Sanders: Innovator in Retroviral Research
Introduction
David A Sanders is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of retroviral research, holding a total of 2 patents. His work focuses on the development of pseudotyped retroviruses, which have important applications in gene therapy and virology.
Latest Patents
David A Sanders' latest patents include innovative methods and compositions related to pseudotyped retroviruses. One of his patents describes a pseudotyped retrovirus with modified Ebola glycoprotein. This invention provides methods for creating these pseudotyped retroviruses and utilizing them for the transduction of target cells. Additionally, he has developed cells that stably produce these pseudotyped retroviruses, which can have a broad host range. His work also includes methods for screening agents that block viral entry into cells, as well as kits for forming these inventive pseudotyped retroviruses.
Career Highlights
Throughout his career, David has worked with reputable organizations such as the Purdue Research Foundation and the Centers for Disease Control and Prevention. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
David A Sanders has collaborated with notable colleagues, including Scott A Jeffers and Anthony Sanchez. These partnerships have further enriched his research endeavors and have led to significant advancements in the field.
Conclusion
David A Sanders is a distinguished inventor whose work in retroviral research has led to important innovations. His contributions continue to impact the fields of virology and gene therapy, showcasing the importance of his inventions in modern science.